 |
Laura Elizabeth Niklason is a physician, professor and internationally recognized researcher in vascular and lung tissue engineering. She is the Nicholas M. Greene Professor of Anesthesiology and Biomedical Engineering at Yale University[1] and co-founder, chief executive officer and president of Humacyte, a regenerative medicine company developing bioengineered human tissues.[2]
Her work on lab-grown lungs was recognized as one of the top 50 most important inventions of 2010 by Time magazine.[3][4] Niklason was included on Fortune’s “Digital Health Care Leaders” list in 2017 for her work in regenerative medicine.[5]
Niklason was inducted into the National Academy of Inventors in 2014.[6] In 2015, she was elected to the National Academy of Medicine.[7] In 2020, Niklason was elected a member of the National Academy of Engineering for cardiovascular tissue engineering, lung regeneration, and biomedical imaging.[8][9] She holds more than 30 issued or pending patents in the United States.
- ^ "Laura Niklason, PhD, MD". medicine.yale.edu. Retrieved September 21, 2021.
- ^ "Company". HUMACYTE. Retrieved September 21, 2021.
- ^ Staff. "The Entrepreneurs". PharmaVOICE. Retrieved August 6, 2018.
- ^ Park, Alice (November 11, 2010). "The 50 Best Inventions of 2010 - TIME". Time. ISSN 0040-781X. Retrieved September 21, 2021.
- ^ "34 Leaders Who Are Changing Health Care". Fortune. Retrieved September 21, 2021.
- ^ "National Academy of Inventors". Retrieved September 21, 2021.
- ^ anonymous. "Prof. Laura Niklason Elected To The National Academy of Medicine". Yale School of Engineering & Applied Science. Retrieved September 21, 2021.
- ^ anonymous. "Laura Niklason Elected To The National Academy of Engineering". Yale School of Engineering & Applied Science. Retrieved September 21, 2021.
- ^ "Dr. Laura Elizabeth Niklason". United States National Academy of Engineering. Retrieved October 9, 2023.